Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
- Products
-
- Cinacalcet Hydrochloride Tablets
- Company
- Cipla USA, Inc.
- Where it was sold
-
Nationwide in the US
Nationwide
- Units affected
- 15,744 bottles
- About this recall
- Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-411-02